Home/Filings/4/0001225208-14-021202
4//SEC Filing

THRESHOLD PHARMACEUTICALS INC 4

Accession 0001225208-14-021202

CIK 0001183765operating

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 7:09 PM ET

Size

20.0 KB

Accession

0001225208-14-021202

Insider Transaction Report

Form 4
Period: 2014-10-01
SWEET DAVID E
10% Owner
Transactions
  • Exercise of In-Money

    Common Stock

    2014-10-01$2.05/sh+417,050$854,9524,942,055 total(indirect: By Partnership)
  • Exercise of In-Money

    Common Stock

    2014-10-01$2.05/sh+3,798$7,78641,859 total(indirect: By Trust)
  • Exercise of In-Money

    Common Stock

    2014-10-01$2.05/sh+797$1,63411,745 total(indirect: By Trust)
  • Exercise of In-Money

    Common Stock Warrant

    2014-10-017970 total(indirect: By Trust)
    Exercise: $2.05From: 2009-10-05Exp: 2014-10-05Common Stock (797 underlying)
  • Sale

    Common Stock

    2014-10-01$3.77/sh226,657$854,9504,715,398 total(indirect: By Partnership)
  • Sale

    Common Stock

    2014-10-01$3.77/sh433$1,63311,312 total(indirect: By Trust)
  • Exercise of In-Money

    Common Stock Warrant

    2014-10-01417,0500 total(indirect: By Partnership)
    Exercise: $2.05From: 2009-10-05Exp: 2014-10-05Common Stock (417,050 underlying)
  • Exercise of In-Money

    Common Stock Warrant

    2014-10-013,7980 total(indirect: By Trust)
    Exercise: $2.05From: 2009-10-05Exp: 2014-10-05Common Stock (3,798 underlying)
  • Sale

    Common Stock

    2014-10-01$3.77/sh2,064$7,78539,795 total(indirect: By Trust)
Footnotes (4)
  • [F1]Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a Managing Director of the General Partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
  • [F2]On October 1, 2014, the reporting person exercised a warrant to purchase shares of the issuer's common stock for $2.05 per share. In accordance with the terms of the warrant, the exercise price was paid on a net basis. The shares disposed of in column 4 represent the number of shares of common stock withheld by the issuer to pay the exercise price.
  • [F3]Shares held by SHV Profit Sharing Plan, a retirement trust, for the benefit of the reporting person.
  • [F4]Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Documents

1 file

Issuer

THRESHOLD PHARMACEUTICALS INC

CIK 0001183765

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001183765

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 7:09 PM ET
Size
20.0 KB